Jane Street Group LLC Buys 99,671 Shares of Personalis, Inc. (NASDAQ:PSNL)

Jane Street Group LLC raised its stake in shares of Personalis, Inc. (NASDAQ:PSNL - Free Report) by 154.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 164,281 shares of the company's stock after buying an additional 99,671 shares during the period. Jane Street Group LLC owned 0.31% of Personalis worth $884,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of PSNL. ARK Investment Management LLC boosted its holdings in shares of Personalis by 11.4% during the 3rd quarter. ARK Investment Management LLC now owns 7,085,523 shares of the company's stock worth $38,120,000 after buying an additional 723,637 shares during the period. Walleye Capital LLC acquired a new position in Personalis during the 3rd quarter worth $897,000. Centiva Capital LP bought a new stake in Personalis during the third quarter valued at about $380,000. Semanteon Capital Management LP acquired a new stake in shares of Personalis in the third quarter valued at about $375,000. Finally, Acadian Asset Management LLC increased its stake in shares of Personalis by 6.7% in the second quarter. Acadian Asset Management LLC now owns 1,057,956 shares of the company's stock worth $1,237,000 after purchasing an additional 66,128 shares during the period. 61.91% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. HC Wainwright increased their target price on Personalis from $9.00 to $11.00 and gave the company a "buy" rating in a research note on Friday, December 20th. Needham & Company LLC reissued a "buy" rating and issued a $7.25 price objective on shares of Personalis in a research report on Friday, December 20th.

Personalis Price Performance

Shares of NASDAQ PSNL traded up $0.49 during mid-day trading on Thursday, hitting $6.27. The company had a trading volume of 1,257,323 shares, compared to its average volume of 773,230. Personalis, Inc. has a 12 month low of $1.12 and a 12 month high of $7.20. The firm has a market cap of $442.96 million, a P/E ratio of -3.73 and a beta of 1.88. The business's 50-day simple moving average is $4.60 and its 200-day simple moving average is $4.17.

Personalis (NASDAQ:PSNL - Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The company reported ($0.64) EPS for the quarter, missing analysts' consensus estimates of ($0.33) by ($0.31). The firm had revenue of $25.71 million during the quarter, compared to the consensus estimate of $20.67 million. Personalis had a negative return on equity of 66.07% and a negative net margin of 104.52%. During the same quarter in the prior year, the business posted ($0.51) EPS. As a group, sell-side analysts predict that Personalis, Inc. will post -1.41 EPS for the current year.

Personalis Company Profile

Personalis, Inc develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection.